Wednesday’s Top Biopharma Movers
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight…
All Work
Chris Lange
What to Expect From Companies Reporting Thursday
The Trump rally has helped push the broad markets to new highs, and with earnings season kicking off on Friday, we can see what this rally is made of.
Why Wells Fargo Says Sell Exxon Mobil, Prefers 4 Other Oil Leaders
For the most part, Wells Fargo has maintained its ratings for integrated oil and gas and international exploration and production companies within its coverage universe, with one key exception.
How SUPERVALU Lost in Q3
SUPERVALU reported disappointing fiscal third-quarter financial results before the markets opened on Wednesday.
Tuesday’s Top Biopharma Movers
Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year, the health care sector was in trouble under fire from congressional hearings and politicians…
Chipotle Rises Despite Weak Comps and Guidance
Shares of Chipotle Mexican Grill saw a handy gain on Tuesday, even though the company reported less-than-favorable preliminary numbers for the fourth quarter.
Why AEP May Be the Most Attractive Utility Stock in America
After years of enjoying dividend growth and investor demand, the U.S. electric utility group finally took a breather in 2016. After all, the post-election rally favored growth over income and defensive stocks.
3 IPOs on the Horizon
As markets reach toward new highs, more companies are considering entering the market. Generally speaking, a rising tide does lift all the boats.
Why Valeant Is Making a Run
Valeant Pharmaceuticals made waves early on Tuesday after the company offered announcements of a late-stage psoriasis trial and the sale of a couple business segments.
How Barracuda Posted a Win for Q3 Earnings
Barracuda Networks reported better-than-expected fiscal third-quarter earnings report after the markets closed on Monday.
Monday’s Merger That No One Saw Coming
Mergers and acquisitions are a way for companies to come together and complement each other’s business models. However, one acquisition stood out on Monday that had some investors scratching their heads.
Monday’s 4 Biggest Biopharma Movers
As the second week of the New Year is now underway, a few biotech companies made sizable runs to kick off the week.
What to Expect From 3 Major Bank Earnings
Three major banks are reporting their fourth-quarter financial results before the markets open on Friday. In general, financial stocks have made solid gains through the end of 2016, with a tremendous tailwind from the…
4 Companies That Destroyed Shareholders Last Week
Although the tailwind of the Trump rally has been incredibly strong, there are still companies holding back this rally. In fact, the Dow was just barely short of hitting the 20,000 mark for the…
Friday’s 6 Biopharma Movers That Can’t Be Ignored
2017 could be different for the health care sector. It is very possible that this new administration could lead to more positive trials, FDA approvals, and mergers and acquisitions.
6 Major FDA Decisions and Biopharma Catalysts Coming in January and February
Some biopharma companies can see a massive upside just from winning a single mid-stage trial or even achieving as much as a Fast Track designation from the FDA.
3 of Thursday’s Biggest Earnings Reports
The Trump rally has helped push the broad markets to new highs, and 24/7 Wall St. has put together a peek of few companies that have just reported their most recent earnings.
Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday
As the markets are continuing to heat up, a few biopharma stocks made massive gains on Thursday. There is a very positive sentiment in the health care sector in anticipation of the new Trump…
2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
Wednesday’s Top 5 Biopharma Movers
A few biotech and pharma companies were on the move Wednesday, some making absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care sector…